USE OF MITOXANTRONE LIPOSOME FOR TREATING NON-HODGKIN'S LYMPHOMA

Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymph...

Full description

Saved in:
Bibliographic Details
Main Authors XUE, JIANFEI, PENG, YUEYING, CHEN, SHAN, MENG, ZHIBIN, WANG, YUMEI, YAO, XUEKUN, WANG, YAJUAN, YUAN, JING, LUO, HONGMEI, LI, CHUNLEI, WANG, SHIXIA, LOU, KUN
Format Patent
LanguageEnglish
Polish
Published 08.07.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymphoma or peripheral T-cell lymphoma, and more further preferably relapsed or refractory diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The mitoxantrone liposomes are used as single anti-tumor therapeutic agent without being combined with other anti-tumor agents.
Bibliography:Application Number: PL20190833348T